Tuxobertinib (BDTX-189) is a highly selective, allosteric inhibitor targeting oncogenic mutations in EGFR and HER2, demonstrating potent anticancer activity. It has shown efficacy in preclinical in vitro and in vivo models for non-small cell lung cancer and other solid tumors driven by these mutations.
Molekulargewicht:
561.03
Reinheit:
99.22% (May vary between batches)
CAS Nummer:
[2414572-47-5]
Formel:
C29H29ClN6O4
Target-Kategorie:
HER,RIP kinase,EGFR,BTK
Anwendungsbeschreibung:
Solubility: DMSO:41.67 mg/mL (74.27 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten